EXEL
Exelixis Inc
NASDAQ: EXEL · HEALTHCARE · BIOTECHNOLOGY
$44.46
-0.51% today
Updated 2026-04-30
Market cap
$11.35B
P/E ratio
16.08
P/S ratio
4.89x
EPS (TTM)
$2.78
Dividend yield
—
52W range
$34 – $50
Volume
2.7M
Exelixis Inc (EXEL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $98.67M | $113.47M | $117.86M | $151.76M | $185.04M | $289.64M | $47.45M | $31.34M | $25.11M | $37.17M | $191.45M | $452.48M | $853.83M | $967.77M | $987.54M | $1.43B | $1.61B | $1.83B | $2.17B | $2.32B |
| Revenue growth (YoY) | — | +15.0% | +3.9% | +28.8% | +21.9% | +56.5% | -83.6% | -34.0% | -19.9% | +48.0% | +415.0% | +136.3% | +88.7% | +13.3% | +2.0% | +45.3% | +12.3% | +13.6% | +18.5% | +7.0% |
| Cost of revenue | $820000.00 | $202000.00 | $280.68M | $261.07M | $233.16M | $183.14M | $155.00M | $1.12M | $2.04M | $3.90M | $6.55M | $15.07M | $26.35M | $33.10M | $36.27M | $52.87M | $57.91M | $72.55M | $76.22M | $83.70M |
| Gross profit | $97.85M | $113.27M | $117.86M | $151.76M | $185.04M | $289.64M | $47.45M | $30.22M | $23.07M | $33.28M | $184.90M | $437.41M | $827.48M | $934.68M | $951.27M | $1.38B | $1.55B | $1.76B | $2.09B | $2.24B |
| Gross margin | 99.2% | 99.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.4% | 91.9% | 89.5% | 96.6% | 96.7% | 96.9% | 96.6% | 96.3% | 96.3% | 96.4% | 96.0% | 96.5% | 96.4% |
| R&D | $185.48M | $225.38M | $257.39M | $234.70M | $210.68M | $156.84M | $128.88M | $178.76M | $189.10M | $96.35M | $95.97M | $112.17M | $182.26M | $336.96M | $547.85M | $693.72M | $891.81M | $1.04B | $910.41M | $825.00M |
| SG&A | $39.12M | $44.94M | $36.89M | $34.38M | $33.02M | $33.13M | $31.84M | $50.96M | $50.83M | $57.30M | $116.14M | $159.36M | $206.37M | $228.24M | $293.36M | $401.71M | $459.86M | $542.71M | $492.13M | $467.03M |
| Operating income | $-126.75M | $-157.05M | $-179.31M | $-121.91M | $-91.40M | $89.53M | $-122.44M | $-200.73M | $-224.46M | $-121.42M | $-28.12M | $165.91M | $438.86M | $369.47M | $110.06M | $286.67M | $201.48M | $170.88M | $604.62M | $872.19M |
| Operating margin | -128.5% | -138.4% | -152.1% | -80.3% | -49.4% | 30.9% | -258.0% | -640.5% | -893.9% | -326.6% | -14.7% | 36.7% | 51.4% | 38.2% | 11.1% | 20.0% | 12.5% | 9.3% | 27.9% | 37.6% |
| EBITDA | $-109.84M | $-157.05M | $-155.58M | $-115.58M | $-72.52M | $100.07M | $-114.73M | $-196.36M | $-212.52M | $-119.97M | $-22.35M | $167.22M | $452.09M | $377.82M | $119.20M | $300.30M | $222.36M | $196.60M | $718.75M | $921.76M |
| EBITDA margin | -111.3% | -138.4% | -132.0% | -76.2% | -39.2% | 34.6% | -241.8% | -626.6% | -846.3% | -322.7% | -11.7% | 37.0% | 52.9% | 39.0% | 12.1% | 20.9% | 13.8% | 10.7% | 33.1% | 39.7% |
| EBIT | $-126.75M | $-168.38M | $-168.81M | $-128.17M | $-83.06M | $93.25M | $-120.45M | $-199.51M | $-214.91M | $-121.37M | $-23.35M | $166.04M | $444.32M | $369.47M | $110.06M | $286.67M | $201.48M | $170.88M | $689.95M | $892.70M |
| Interest expense | $4.99M | $3.97M | $6.76M | $12.67M | $9.34M | $16.26M | $27.09M | $45.35M | $41.36M | $40.68M | $33.06M | $8.68M | $0.00 | $0.00 | $0.00 | $0.00 | $53.74M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-101.49M | $-86.38M | $-162.85M | $-135.22M | $-92.33M | $75.70M | $-147.65M | $-244.76M | $-268.54M | $-169.74M | $-70.22M | $154.23M | $690.07M | $321.01M | $111.78M | $231.06M | $182.28M | $207.76M | $521.27M | $782.57M |
| Net income growth (YoY) | — | +14.9% | -88.5% | +17.0% | +31.7% | +182.0% | -295.0% | -65.8% | -9.7% | +36.8% | +58.6% | +319.6% | +347.4% | -53.5% | -65.2% | +106.7% | -21.1% | +14.0% | +150.9% | +50.1% |
| Profit margin | -102.9% | -76.1% | -138.2% | -89.1% | -49.9% | 26.1% | -311.2% | -781.0% | -1069.4% | -456.6% | -36.7% | 34.1% | 80.8% | 33.2% | 11.3% | 16.1% | 11.3% | 11.4% | 24.0% | 33.7% |